Kazia Therapeutics Ltd is a biotechnology company focused on pharmaceutical drug development in oncology. The company has a portfolio of development candidates across various technologies targeting multiple cancer indications. Its primary program is Paxalisib, an investigational brain-penetrant inhibitor of the PI3K/Akt/mTOR pathway, designed for the treatment of brain cancer. The company develops targeted therapies aimed at addressing medical needs in oncology. The company operates in Australia and the United States.
Show more...
FAQ
Kazia Therapeutics Limited 今天的股價是多少?▼
KZIA 目前價格為 $13.41 USD,過去 24 小時下跌了 -1.94%。在圖表上更密切關注 Kazia Therapeutics Limited 股票的表現。
Kazia Therapeutics Limited 的股票代號是什麼?▼
根據交易所不同,股票代號可能會有所差異。例如,在 XNAS 交易所,Kazia Therapeutics Limited 的股票以代號 KZIA 進行交易。
Kazia Therapeutics Limited 的股價在上漲嗎?▼
KZIA 股票較上週下跌 -0.85%,本月下跌 -8.18%,但在過去一年中,Kazia Therapeutics Limited 上漲了 +73.87%。
Kazia Therapeutics Limited 的市值是多少?▼
今天 Kazia Therapeutics Limited 的市值為 153.18M
Kazia Therapeutics Limited 去年的營收是多少?▼
Kazia Therapeutics Limited 去年的營收為 27,622.14USD。
Kazia Therapeutics Limited 去年的淨利是多少?▼
KZIA 去年的淨收益為 -13.21MUSD。
Kazia Therapeutics Limited 有多少名員工?▼
截至 August 22, 2026,公司共有 6 名員工。
Kazia Therapeutics Limited 位於哪個產業?▼
Kazia Therapeutics Limited從事於Health & Wellness產業。
Kazia Therapeutics Limited 何時完成拆股?▼
Kazia Therapeutics Limited 上次拆股發生於 April 17, 2025,比例為 1:5。
Kazia Therapeutics Limited 的總部在哪裡?▼
Kazia Therapeutics Limited 的總部位於 澳洲 的 NEW SOUTH WALES 2113。